Corvus Pharmaceuticals CRVS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$15.28M+75.5% | -$62.29M-130% | -$27.03M+34.6% | -$41.31M+4.5% | ||
| $105K+23.5% | $85K-43.7% | $151K-58.9% | $367K-20.2% | ||
| $5.33M+77.5% | $3M+39.9% | $2.15M-20.2% | $2.69M-36.4% | ||
| -$32.8M-29.0% | -$25.42M-6.2% | -$23.94M+11.4% | -$27.02M+26.4% | ||
| $174K— | —— | —— | —— | ||
| —— | -$27.48M— | —— | —— | ||
| $36.43M— | —— | $7.86M— | $0-100% | ||
| —— | —— | -$539K+98.9% | -$50.3M— | ||
| -$32.97M— | —— | -$23.97M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Corvus Pharmaceuticals generate?
- Corvus Pharmaceuticals (CRVS) generated -$34.9M in operating cash flow over the trailing twelve months.
- What is Corvus Pharmaceuticals's free cash flow?
- After $229.0K of capital expenditures, Corvus Pharmaceuticals's free cash flow was -$35.1M over the trailing twelve months, down 45.7% year over year.
- Where does Corvus Pharmaceuticals's cash flow data come from?
- Every line is extracted from Corvus Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.